Details werden geladen...
Lower-cost alternatives to cancer drugs may cut treatment costs | UCLA
A UCLA study of more than 14,000 patient-drug pairs finds insurers and patients paid less for biosimilars than for brand-name biologics.
Ähnliche Seiten
Young women diagnosed with breast cancer within 3 years of childbirth may face more aggressive disease, UCLA study finds | UCLA
https://newsroom.ucla.edu/releases/breast-cancer-risk-women-after-childbirth-ucla-study
Yogurt May Lower Colon Cancer Risk, Study Finds
https://www.webmd.com/colorectal-cancer/features/can-yogurt-help-colon-cancerCreatine may supercharge immune cells that are key to fighting cancer | UCLA
https://newsroom.ucla.edu/releases/creatine-may-supercharge-immune-cells-key-to-fighting-cancer
Breast cancer survivors whose treatment led to heart problems 'may not need drugs for life' | Daily Mail Online
https://www.dailymail.com/health/article-16091807/Breast-cancer-survivors-treatment-led-heart-problems-not-need-drugs-life.html
Government may lift price cap on cancer drugs making them costlier by up to 50% - The Economic Times
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/government-may-lift-price-cap-cancer-drugs-making-them-costlier-by-up-to-50/articleshow/131642041.cms